Pharmaceutical research provider Aquila BioMedical has moved to a purpose built ‘BioQuarter’, called Nine, ahead of a planned investment round.

The Edinburgh University spin-out, based in the Scottish capital, has been situated on campus at the Queens Medical Research Institute since it was founded in 2011. The company has indicated that an increased interest in its activities has paved the way for the move.

The firm supports academic experts and clinicians by conducting and delivering high-quality research. It offers clients…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?